PC
PFE icon

Polar Capital’s Pfizer PFE Stock Holding History

Polar Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-563,805
Closed -$21M – 309
2019
Q4 		$21M Sell
563,805
-482,278
-46% -$17.2M 0.18% 149
2019
Q3 		$35.7M Sell
1,046,083
-1,514,692
-59% -$55.1M 0.32% 95
2019
Q2 		$105M Buy
2,560,775
+127,004
+5% +$5.04M 0.92% 22
2019
Q1 		$98.1M Buy
2,433,771
+527,000
+28% +$21.1M 0.91% 24
2018
Q4 		$79M Sell
1,906,771
-947,629
-33% -$39.3M 0.84% 27
2018
Q3 		$119M Buy
2,854,400
+499,714
+21% +$19.2M 1.02% 23
2018
Q2 		$81.1K Buy
2,354,686
+186,475
+9% +$6.37M 0.49% 35
2018
Q1 		$73M Buy
2,168,211
+246,058
+13% +$8.46M 0.74% 30
2017
Q4 		$66.1M Sell
1,922,153
-99,358
-5% -$3.39M 0.68% 30
2017
Q3 		$68.5M Hold
2,021,511
– – 0.77% 34
2017
Q2 		$64.4M Sell
2,021,511
-891,684
-31% -$28.1M 0.87% 32
2017
Q1 		$94.5M Sell
2,913,195
-231,494
-7% -$7.3M 1.42% 12
2016
Q4 		$96.9M Buy
3,144,689
+245,624
+8% +$7.5M 1.55% 14
2016
Q3 		$93.2M Sell
2,899,065
-1,979,467
-41% -$66.2M 1.61% 8
2016
Q2 		$163M Buy
4,878,532
+1,894,620
+63% +$60.5M 3.08% 2
2016
Q1 		$83.9M Buy
2,983,912
+103,073
+4% +$2.94M 1.58% 9
2015
Q4 		$88.2M Sell
2,880,839
-2,457,511
-46% -$77.3M 1.6% 8
2015
Q3 		$159M Buy
5,338,350
+1,025,998
+24% +$32.9M 3.22% 3
2015
Q2 		$137M Sell
4,312,352
-270,742
-6% -$8.82M 2.64% 3
2015
Q1 		$151M Buy
4,583,094
+1,828,140
+66% +$58.1M 2.86% 3
2014
Q4 		$81.4M Sell
2,754,954
-548,513
-17% -$15.7M 1.59% 5
2014
Q3 		$92.7M Buy
3,303,467
+252,738
+8% +$7.09M 1.94% 4
2014
Q2 		$85.9M Buy
3,050,729
+265,799
+10% +$7.58M 1.83% 4
2014
Q1 		$84.9M Buy
2,784,930
+774,885
+39% +$23.1M 1.94% 4
2013
Q4 		$58.4M Buy
2,010,045
+137,416
+7% +$4M 1.39% 7
2013
Q3 		$51K Buy
1,872,629
+366,842
+24% +$9.98M 1.36% 7
2013
Q2 		$40M Buy
+1,505,787
New +$41.6M 1.39% 8

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Polar Capital's PFE Position: Q1 2020 in Review

Polar Capital sold out of Pfizer (PFE) in Q1 2020, closing a stake of 563,805 shares — an estimated $21M sold.

Polar Capital first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $163M in Q2 2016. 2,437 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Polar Capital reported no remaining Pfizer position as of Q1 2020 after selling out during the quarter.
  • Polar Capital sold 563,805 Pfizer shares in Q1 2020, an estimated $21M.
  • Polar Capital first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • Polar Capital's Pfizer position peaked at $163M in Q2 2016.
  • 2,437 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Polar Capital's 13F filing for Q1 2020, filed 15 May 2020.